Modification date 08-04-2025 | 15:14

 From 14 April 2025 until late summer 2025, men who have sex with men (MSM contact) and transgender people who have a high risk of getting mpox can be vaccinated against mpox by the Municipal Public Health Services (GGDs).

Who is eligible to get the mpox vaccination?

Vaccination against mpox is men who have sex with men (MSM contact) and transgender people who have a higher risk of getting mpox.

You are eligible for mpox vaccination if you have MSM contact and/or are transgender, AND one or more of the following applies to you:

  • You are using HIV-PrEP;
  • You are on the waiting list for HIV-PrEP;
  • You have had more than 10 sexual partners in the past six months;
  • You go to sex venues and/or sex parties;
  • You engage in group sex;
  • You have a HIV infection and were eligible for mpox vaccination based on the previous screening criteria (hepatitis C screening as an indicator of high-risk behaviour)..

Can I currently get a vaccination against mpox?

From 14 April 2025 on, men who have sex with men (MSM contact) and transgender people who have a higher risk of getting mpox are eligible for vaccination against mpox. These people can contact the Municipal Public Health Service (GGD) on their own initiative to make a vaccination appointment. Close contacts and sexual contacts of people with a confirmed mpox infection can be vaccinated in consultation with the GGD.

Be alert to symptoms

Always keep an eye out for possible mpox symptoms – even if you were vaccinated. If symptoms occur, contact the Municipal Public Health Services (GGDs) or your GP immediately to get tested. Avoid sexual contact and all direct contact with the skin until the test result is known.

Side effects of mpox vaccination

Vaccination against mpox can cause side effects. The most common side effects are pain, redness and swelling at the injection site. You may also have muscle pain, headache, nausea, and fever or elevated temperature. Possible side effects should always be reported  to Pharmacovigilance Centre Lareb.

Privacy

RIVM processes personal data with your consent to ensure proper management of the mpox vaccination programme. This privacy statement explains which data will be processed by RIVM and why, and what rights you have when RIVM processes your data.

More information